A Study of Erlotinib in Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer
Clinical trial NCT02694536 · COMPLETED
Trial details
- NCT number
- NCT02694536
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2009-11-19
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.